Pennsylvania Regulations: Communicable and Noncommunicable Diseases
Comment: Submitted to the Pennsylvania Department of Health
Substance Use Disorder
Policy

On March 21st, 2024, Ashish Thakrar, MD, MS, LDI Associate Fellow from the Perelman School of Medicine; Sarah S. Kawasaki, MD, Current OTP Medical Director Associate Professor of Medicine Penn State Health; Nicole O’Donnell, Project Manager Penn Center for Addiction Medicine & Policy (CAMP); and Julia Hinckley, JD, Director of Policy Strategy at LDI conducted a virtual briefing for a bipartisan group of staff from the U.S. House of Representatives regarding proposed Modernizing Opioid Treatment Access Act legislation to increase access to methadone to address the U.S. overdose epidemic. This team of experts outlined evidence suggesting that expanding who can prescribe methadone would reduce overdose deaths.
Views expressed by the researchers are their own and do not necessarily represent those of the University of Pennsylvania Health System (Penn Medicine) or the University of Pennsylvania.
Comment: Submitted to the Pennsylvania Department of Health
Comment: Submitted to the Food and Drug Administration
Comment: Delivered to the Office of Management and Budget
Testimony: Delivered to Philadelphia City Council’s Committee on Public Health and Human Services by Amy Hillier
Testimony: Delivered to Philadelphia City Council’s Committee on Public Health and Human Services by Aaron Richterman
Testimony: Delivered to the Center for Rural Pennsylvania Board of Directors Public Hearing